Lupin Shares Recover Following VISUfarma Acquisition, Up ~250% Over 3 Years

Parth DSIJ / 02 Apr 2026 / Categories: Mindshare, Trending

Lupin Shares Recover Following VISUfarma Acquisition, Up ~250% Over 3 Years

Lupin Ltd completes VISUfarma acquisition, expands its ophthalmology portfolio in Europe, and shows strong stock performance with ~250 per cent returns over three years. 

Lupin Ltd (Lupin) has completed the acquisition of VISUfarma B.V. (VISUfarma). VISUfarma is a leading European speciality pharmaceutical company focused on ophthalmology. The company was acquired from GHO Capital Partners LLP (GHO).

This acquisition is an important step in Lupin’s strategy to grow its speciality care portfolio. It also strengthens Lupin’s presence in Europe.

With VISUfarma, Lupin’s ophthalmology portfolio now includes over 60 branded products. These products cover areas such as dry eye, glaucoma, eyelid hygiene, blepharitis, retinal health, and speciality nutraceuticals.

VISUfarma has a strong commercial presence in Europe. Key markets include Italy, the UK, Spain, Germany, and France. The company also brings a skilled team with deep ophthalmology expertise. They have trusted relationships and strong local market knowledge.

The acquisition helps Lupin meet the growing global demand for eye care solutions. This demand is driven by an ageing population and an increase in diabetes-related eye problems.

About Lupin Ltd

Lupin Ltd is a global pharmaceutical company based in Mumbai, India. Its products are sold in over 100 countries. The company makes branded and generic medicines, complex generics, biotechnology products, and active pharmaceutical ingredients.

Lupin is trusted by doctors and patients worldwide. It has a strong presence in India and the U.S. The company works in many therapy areas, including respiratory, heart, diabetes, infections, digestive health, brain and nervous system, and women’s health.

Lupin Ltd Share Price Performance

As of April 02, 2026, at 12:42:42 IST, Lupin Ltd’s share price was trading at Rs 2,254.20, down Rs 23.60 or 1.04 per cent from the previous close of Rs 2,274.90. During the Intraday session, the stock opened at Rs 2,269.20 and moved between a high of Rs 2,269.20 and a low of Rs 2,170.10 before reaching the current level.

Looking at past performance, Lupin has delivered solid returns. On a year-to-date basis, the stock has gained 7.04 per cent. Over the last year, it has risen by 12.00 per cent. Over the past three years, the stock has delivered a remarkable return of 247.13 per cent.

Not every stock is a winner—but some multiply wealth manifold. DSIJ's multibagger Pick filters these rare gems through rigorous analysis & decades of expertise. Get the Full Brochure

Disclaimer: The article is for informational purposes only and not investment advice.